Buchbinder Aby 4
4 · ENZON PHARMACEUTICALS INC · Filed Sep 19, 2011
Insider Transaction Report
Form 4
Buchbinder Aby
VP, Clinical Development
Transactions
- Tax Payment
Common Stock
2011-09-15$8.33/sh−2,952$24,590→ 56,715 total
Footnotes (1)
- [F1]The Shares were withheld from the Reporting Person, in an exempt transaction under Rule 16b-3, solely to satisfy tax obligations arising from the accelerated vesting of certain previously reported restricted stock units upon the Reporting Person's achievement of certain performance milestones determined by the Board of Directors of the Issuer.